IID50300
Breast cancer type 2 susceptibility protein homolog (Rattus norvegicus) O35923
:order :disorder :conflict :PDB cluster :ProS :SCOP Domain :Pfam Domain
Experiment
3343
fasta
order/disorder by at least rule
disorder by at least rule
order/disorder by majority rule
Seq 2335-3151 Hetero dimer : P60896
Region 1iyj D 2335-2402 disorder
Region 1iyj D 2403-2627 order
Region 1iyj D 2628-2644 disorder
Region 1iyj D 2645-2784 order
Region 1iyj D 2785-2891 disorder
Region 1iyj D 2892-3117 order
Region 1iyj D 3118-3151 disorder
Region 1iyj B 2335-2402 disorder
Region 1iyj B 2403-2627 order
Region 1iyj B 2628-2644 disorder
Region 1iyj B 2645-2784 order
Region 1iyj B 2785-2891 disorder
Region 1iyj B 2892-3117 order
Region 1iyj B 3118-3151 disorder
3222-3222 Phosphoserine; by CDK1 and CDK2
Prediction
Disorder 1-5,38-130,166-195,236-464,495-550,583-996,1034-1196,1233-1504,1586-1693,1846-2407,3143-3343
Known Domain 1505-1536,1694-1761,2408-3142
Cryptic Domain 6-37,131-165,196-235,465-494,551-582,997-1033,1197-1232,1537-1585,1762-1845
PF09169 2411-2596 2e-60 BRCA2, helical
PF09103 2600-2724 2e-35 BRCA2, oligonucleotide/ol...
PF09121 2761-2802 2e-11 Tower
PF09104 2980-3111 7e-44 BRCA2, oligonucleotide/ol...
PF00634 989-1017 5.4e-10 BRCA2 repeat
PF00634 1198-1230 2.7e-15 BRCA2 repeat
PF00634 1407-1437 6.3e-15 BRCA2 repeat
PF00634 1504-1534 1e-11 BRCA2 repeat
PF00634 1639-1669 1.5e-12 BRCA2 repeat
PF00634 1943-1972 1.3e-13 BRCA2 repeat
PF00634 2023-2051 1.3e-10 BRCA2 repeat
PF09169 2412-2597 1.5e-92 BRCA2, helical
PF09103 2600-2725 1.9e-44 BRCA2, oligonucleotide/o...
PF09121 2761-2802 1.1e-21 Tower
PF09104 2980-3112 2.5e-52 BRCA2, oligonucleotide/o...